Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-03 Sale | 2024-06-05 7:23 pm | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer | 822,721 | $54.75 | $45,043,975 | 3,515,007 (Indirect Direct) | View |
| 2023-11-13 Purchase | 2023-11-15 4:48 pm | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 849,854 | $5.87 | $4,988,643 | 5,329,346 (Indirect) | View |
| 2021-06-15 Purchase | 2021-06-16 6:11 pm | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 629,411 | $17 | $10,699,987 | 4,652,427 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-03 4:52 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 157,000 | $0 | 157,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:34 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:27 pm | N/A 2032-01-02 | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 116,750 | $0 | 116,750 (Direct) | View |
| 2021-06-15 Conversion | 2021-06-16 6:11 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 6,855,609 | $0 | 4,652,427 (Indirect) | View |
Ownership | 2021-06-10 7:18 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 0 | $0 | 4,215,166 (Direct) | View |
| 2020-01-23 Disposition | 2020-01-24 6:36 pm | N/A 2028-08-29 | Synthorx Inc. | THOR | Reardon Tighe Acting Chief Financial Officer | 18,723 | $63.36 | 0 (Direct) | View |
| 2020-01-23 Disposition | 2020-01-24 6:36 pm | N/A 2028-12-05 | Synthorx Inc. | THOR | Reardon Tighe Acting Chief Financial Officer | 30,000 | $57 | 0 (Direct) | View |
| 2020-01-23 Equity Swap | 2020-01-24 6:36 pm | N/A N/A | Synthorx Inc. | THOR | Reardon Tighe Acting Chief Financial Officer | 1,725,774 | $68 | 0 (Direct) | View |